Torsional Stress Induces an S1 Nuclease-Hypersensitive Site Within
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Predicting Double-Strand DNA Breaks Using Epigenome Marks Or DNA at Kilobase Resolution
bioRxiv preprint doi: https://doi.org/10.1101/149039; this version posted June 12, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Predicting double-strand DNA breaks using epigenome marks or DNA at kilobase resolution Rapha¨elMourad1 and Olivier Cuvier1 April 10, 2017 1 Laboratoire de Biologie Mol´eculaireEucaryote (LBME), CNRS, Universit´ePaul Sabatier (UPS), 31000 Toulouse, France Abstract Double-strand breaks (DSBs) result from the attack of both DNA strands by multiple sources, includ- ing exposure to ionizing radiation or reactive oxygen species. DSBs can cause abnormal chromosomal rearrangements which are linked to cancer development, and hence represent an important issue. Recent techniques allow the genome-wide mapping of DSBs at high resolution, enabling the comprehensive study of DSB origin. However these techniques are costly and challenging. Hence we devised a computational approach to predict DSBs using the epigenomic and chromatin context, for which public data are available from the ENCODE project. We achieved excellent prediction accuracy (AUC = 0:97) at high resolution (< 1 kb), and showed that only chromatin accessibility and H3K4me1 mark were sufficient for highly accurate prediction (AUC = 0:95). We also demonstrated the better sensitivity of DSB predictions com- pared to BLESS experiments. We identified chromatin accessibility, activity and long-range contacts as best predictors. In addition, our work represents the first step toward unveiling the "cis-DNA repairing" code underlying DSBs, paving the way for future studies of cis-elements involved in DNA damage and repair. -
Mutation Detection & Analysis
PRO55 G-Biosciences ♦ 1-800-628-7730 ♦ 1-314-991-6034 ♦ [email protected] A Geno Technology, Inc. (USA) brand name Mutation Detection & Analysis Teacher’s Guidebook (Cat. # BE-314) think proteins! think G-Biosciences www.GBiosciences.com MATERIALS INCLUDED WITH THE KIT ................................................................................ 3 CHECKLIST .......................................................................................................................... 3 SPECIAL HANDLING INSTRUCTIONS ................................................................................... 3 ADDITIONAL EQUIPMENT REQUIRED ................................................................................ 3 TIME REQUIRED ................................................................................................................. 3 OBJECTIVES ........................................................................................................................ 4 BACKGROUND ................................................................................................................... 4 POLYMERASE CHAIN REACTION .................................................................................... 5 RESTRICTION ENZYMES ................................................................................................. 8 TEACHER’S PRE EXPERIMENT SET UP .............................................................................. 11 PREPARE PCR AND RESTRICTION DIGESTION REAGENTS ............................................ 11 -
Npgrj Nmeth 890 511..518
ARTICLES Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays s 1,6 1,2,6 1,2 2 2 2 d Peter J Sabo , Michael S Kuehn , Robert Thurman , Brett E Johnson , Ericka M Johnson , Hua Cao , o h 2 2 1 1 1 1 1 t Man Yu , Elizabeth Rosenzweig , Jeff Goldy , Andrew Haydock , Molly Weaver , Anthony Shafer , Kristin Lee , e 1 1 3 3 1 m Fidencio Neri , Richard Humbert , Michael A Singer , Todd A Richmond , Michael O Dorschner , e r u 4 5 3 2 1 t Michael McArthur , Michael Hawrylycz , Roland D Green , Patrick A Navas , William S Noble & a n 1 / John A Stamatoyannopoulos m o c . e r u Localized accessibility of critical DNA sequences to the entire genome and analysis of their relationship to the current t a n regulatory machinery is a key requirement for regulation of annotation of human genes. Comprehensive delineation of the . w human genes. Here we describe a high-resolution, genome-scale accessible chromatin compartment is expected to be of particular w w / approach for quantifying chromatin accessibility by measuring importance for identification of functional human genetic variants / : p t DNase I sensitivity as a continuous function of genome position that mediate individual variation in gene expression and physio- t h using tiling DNA microarrays (DNase-array). We demonstrate this logical phenotypes. On a broader level, human chromosomes p approach across 1% (B30 Mb) of the human genome, wherein have long been thought to be organized into discrete higher- u o r we localized 2,690 classical DNase I hypersensitive sites with order functional domains characterized by ‘open’ (active) G high sensitivity and specificity, and also mapped larger-scale and ‘closed’ (inactive) chromatin8–10. -
Structures of Restriction Endonuclease Hindiii in Complex with Its Cognate DNA and Divalent Cations
Title Structures of restriction endonuclease HindIII in complex with its cognate DNA and divalent cations Author(s) Watanabe, Nobuhisa; Takasaki, Yozo; Sato, Chika; Ando, Shoji; Tanaka, Isao Acta Crystallographica. Section D, Biological Crystallography, 65(12), 1326-1333 Citation https://doi.org/10.1107/S0907444909041134 Issue Date 2009-12 Doc URL http://hdl.handle.net/2115/39986 Type article File Information watanabe_ActaCristD65.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP electronic reprint Acta Crystallographica Section D Biological Crystallography ISSN 0907-4449 Editors: E. N. Baker and Z. Dauter Structures of restriction endonuclease HindIII in complex with its cognate DNA and divalent cations Nobuhisa Watanabe, Yozo Takasaki, Chika Sato, Shoji Ando and Isao Tanaka Acta Cryst. (2009). D65, 1326–1333 Copyright c International Union of Crystallography Author(s) of this paper may load this reprint on their own web site or institutional repository provided that this cover page is retained. Republication of this article or its storage in electronic databases other than as specified above is not permitted without prior permission in writing from the IUCr. For further information see http://journals.iucr.org/services/authorrights.html Acta Crystallographica Section D: Biological Crystallography welcomes the submission of papers covering any aspect of structural biology, with a particular emphasis on the struc- tures of biological macromolecules and the methods used to determine them. Reports on new protein structures are particularly encouraged, as are structure–function papers that could include crystallographic binding studies, or structural analysis of mutants or other modified forms of a known protein structure. The key criterion is that such papers should present new insights into biology, chemistry or structure. -
A Short History of the Restriction Enzymes Wil A
Published online 18 October 2013 Nucleic Acids Research, 2014, Vol. 42, No. 1 3–19 doi:10.1093/nar/gkt990 NAR Breakthrough Article SURVEY AND SUMMARY Highlights of the DNA cutters: a short history of the restriction enzymes Wil A. M. Loenen1,*, David T. F. Dryden2,*, Elisabeth A. Raleigh3,*, Geoffrey G. Wilson3,* and Noreen E. Murrayy 1Leiden University Medical Center, Leiden, the Netherlands, 2EaStChemSchool of Chemistry, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, Scotland, UK and 3New England Biolabs, Inc., 240 County Road, Ipswich, MA 01938, USA Received August 14, 2013; Revised September 24, 2013; Accepted October 2, 2013 ABSTRACT Type II REases represent the largest group of characterized enzymes owing to their usefulness as tools for recombinant In the early 1950’s, ‘host-controlled variation in DNA technology, and they have been studied extensively. bacterial viruses’ was reported as a non-hereditary Over 300 Type II REases, with >200 different sequence- phenomenon: one cycle of viral growth on certain specificities, are commercially available. Far fewer Type I, bacterial hosts affected the ability of progeny virus III and IV enzymes have been characterized, but putative to grow on other hosts by either restricting or examples are being identified daily through bioinformatic enlarging their host range. Unlike mutation, this analysis of sequenced genomes (Table 1). change was reversible, and one cycle of growth in Here we present a non-specialists perspective on import- the previous host returned the virus to its original ant events in the discovery and understanding of REases. form. These simple observations heralded the dis- Studies of these enzymes have generated a wealth of covery of the endonuclease and methyltransferase information regarding DNA–protein interactions and catalysis, protein family relationships, control of restric- activities of what are now termed Type I, II, III and tion activity and plasticity of protein domains, as well IV DNA restriction-modification systems. -
Promiscuous Restriction Is a Cellular Defense Strategy That Confers Fitness
Promiscuous restriction is a cellular defense strategy PNAS PLUS that confers fitness advantage to bacteria Kommireddy Vasua, Easa Nagamalleswaria, and Valakunja Nagarajaa,b,1 aDepartment of Microbiology and Cell Biology, Indian Institute of Science, Bangalore 560012, India; and bJawaharlal Nehru Centre for Advanced Scientific Research, Bangalore 560064, India Edited by Werner Arber, der Universitat Basel, Basel, Switzerland, and approved March 20, 2012 (received for review November 22, 2011) Most bacterial genomes harbor restriction–modification systems, ognition and cofactor utilization, whereas the cognate MTase is encoding a REase and its cognate MTase. On attack by a foreign very site-specific (14). In addition to its recognition sequence, DNA, the REase recognizes it as nonself and subjects it to restric- GGTACC, the enzyme binds and cleaves a number of noncanoni- tion. Should REases be highly specific for targeting the invading cal sequences (i.e., TGTACC, GTTACC, GATACC, GGAACC, foreign DNA? It is often considered to be the case. However, when GGTCCC, GGTATC, GGTACG, GGTACT), with the binding bacteria harboring a promiscuous or high-fidelity variant of the affinity ranging from 8 to 35 nM (14, 15). Accordingly, many of fi REase were challenged with bacteriophages, tness was maximal these sites are cleaved efficiently with kcat values varying from 0.06 − − under conditions of catalytic promiscuity. We also delineate pos- to 0.15 min 1 vs. 4.3 min 1 for canonical sites (15). The promis- sible mechanisms by which the REase recognizes the chromosome cuous activity of the enzyme is directed by a number of cofactors. as self at the noncanonical sites, thereby preventing lethal dsDNA In the presence of the physiological levels of Mg2+, the most breaks. -
Chromatin Accessibility and the Regulatory Epigenome
REVIEWS EPIGENETICS Chromatin accessibility and the regulatory epigenome Sandy L. Klemm1,4, Zohar Shipony1,4 and William J. Greenleaf1,2,3* Abstract | Physical access to DNA is a highly dynamic property of chromatin that plays an essential role in establishing and maintaining cellular identity. The organization of accessible chromatin across the genome reflects a network of permissible physical interactions through which enhancers, promoters, insulators and chromatin-binding factors cooperatively regulate gene expression. This landscape of accessibility changes dynamically in response to both external stimuli and developmental cues, and emerging evidence suggests that homeostatic maintenance of accessibility is itself dynamically regulated through a competitive interplay between chromatin- binding factors and nucleosomes. In this Review , we examine how the accessible genome is measured and explore the role of transcription factors in initiating accessibility remodelling; our goal is to illustrate how chromatin accessibility defines regulatory elements within the genome and how these epigenetic features are dynamically established to control gene expression. Chromatin- binding factors Chromatin accessibility is the degree to which nuclear The accessible genome comprises ~2–3% of total Non- histone macromolecules macromolecules are able to physically contact chroma DNA sequence yet captures more than 90% of regions that bind either directly or tinized DNA and is determined by the occupancy and bound by TFs (the Encyclopedia of DNA elements indirectly to DNA. topological organization of nucleosomes as well as (ENCODE) project surveyed TFs for Tier 1 ENCODE chromatin- binding factors 13 Transcription factor other that occlude access to lines) . With the exception of a few TFs that are (TF). A non- histone protein that DNA. -
NF1) Pseudogenes on Chromosomes 2, 14 and 22
European Journal of Human Genetics (2000) 8, 209–214 © 2000 Macmillan Publishers Ltd All rights reserved 1018–4813/00 $15.00 y www.nature.com/ejhg ARTICLE Mechanism of spreading of the highly related neurofibromatosis type 1 (NF1) pseudogenes on chromosomes 2, 14 and 22 Mirjam Luijten1, YingPing Wang2, Blaine T Smith2, Andries Westerveld1, Luc J Smink3, Ian Dunham3, Bruce A Roe2 and Theo JM Hulsebos1 1Department of Human Genetics, Academic Medical Center, University of Amsterdam, The Netherlands; 2Department of Chemistry and Biochemistry, University of Oklahoma, Norman, OK, USA; 3Sanger Centre, Wellcome Trust Genome Campus, Hinxton Hall, Cambridge, UK Neurofibromatosis type 1 (NF1) is a frequent hereditary disorder that involves tissues derived from the embryonic neural crest. Besides the functional gene on chromosome arm 17q, NF1-related sequences (pseudogenes) are present on a number of chromosomes including 2, 12, 14, 15, 18, 21, and 22. We elucidated the complete nucleotide sequence of the NF1 pseudogene on chromosome 22. Only the middle part of the functional gene but not exons 21–27a, encoding the functionally important GAP-related domain of the NF1 protein, is presented in this pseudogene. In addition to the two known NF1 pseudogenes on chromosome 14 we identified two novel variants. A phylogenetic tree was constructed, from which we concluded that the NF1 pseudogenes on chromosomes 2, 14, and 22 are closely related to each other. Clones containing one of these pseudogenes cross-hybridised with the other pseudogenes in this subset, but did not reveal any in situ hybridisation with the functional NF1 gene or with NF1 pseudogenes on other chromosomes. -
Anza Restriction Enzyme Cloning System Complete, One-Buffer System— for Beautifully Simple Cloning Cloning Has Never Been Simpler
Anza Restriction Enzyme Cloning System Complete, one-buffer system— for beautifully simple cloning Cloning has never been simpler Finally, forget the frustrations of finding compatible buffers and sorting through protocols for your restriction enzyme digests—start getting reliable results for your downstream experiments. The Invitrogen™ Anza™ Restriction Enzyme Cloning System is a complete system, comprised of: DNA modifying enzymes 128 restriction enzymes + 5 DNA modifying enzymes Anza T4 DNA Ligase Master Mix Anza Thermosensitive All Anza™ restriction enzymes work together cohesively and are fully functional Alkaline Phosphatase with the single Anza™ buffer. Anza T4 Polynucleotide Kinase The system offers: Anza DNA Blunt End Kit • One buffer for all restriction enzymes Anza DNA End Repair Kit • One digestion protocol for all DNA types • Complete digestion in 15 minutes • Overnight digestion without star activity Convenient buffer formats All Anza restriction enzymes come with an Anza 10X Buffer and an Anza 10X Red Buffer to give you the flexibility you require. The red buffer includes a density reagent containing red and yellow tracking dyes that migrate with 800 bp DNA fragments and faster than the 10 bp DNA fragments, respectively, in a 1% agarose gel. This eliminates tedious dye addition steps prior to gel loading and is compatible with downstream applications.* * For applications that require analysis by fluorescence excitation, Anza 10X Buffer is recommended, as the Anza 10X Red Buffer may interfere with some fluorescence measurements. 2 A one-buffer system Eliminate the frustration of trying to find compatible buffers for all your enzymes. All Anza restriction enzymes allow for complete digestion using a single Anza buffer. -
2019-20 NEB Catalog Technical Reference
Reference Appendix Technical Support – Featured Tools & for scientists, by scientists Resources As a partner to the scientific community, New England Biolabs is committed to Optimizing Restriction Enzyme Reactions providing top quality tools and scientific expertise. This philosophy still stands, 290 and has led to long-standing relationships with many of our fellow scientists. Performance Chart for NEB's commitment to scientists is the same regardless of whether or not they 293 Restriction Enzymes purchase product from NEB: their ongoing research is supported by our catalog, Troubleshooting Guide website and technical staff. 349 for Cloning NEB's technical support model is unique as it utilizes most of the scientists at NEB. Several of our product lines have designated technical support scientists 334 Methylation Sensitivity assigned to servicing customers in those application areas. Any questions regarding a product could be dealt with by one of the technical support Guidelines for scientists, the product manager who manufactures it, the product development 337 PCR Optimization scientist who optimizes it, or a researcher who uses the product in their daily Cleavage Close to the research. As such, customers are supported by scientists and often experts in 343 End of DNA Fragments the product or its application. To access technical support: 288 Online Interactive Tools Call 1-800-632-7799 (Monday – Friday: 9:00 am - 6:00 pm EST) Submit an online form at www.neb.com/techsupport View NEB TV Episode #22 Email [email protected] to learn more about our Technical Support program. International customers can contact a local NEB subsidiary or distributor. For more information see inside back cover. -
Targeting Mutations to the Plastidial Psba Gene of Chlamydomonas
www.nature.com/scientificreports OPEN Targeting mutations to the plastidial psbA gene of Chlamydomonas reinhardtii without Received: 15 January 2019 Accepted: 3 April 2019 direct positive selection Published: xx xx xxxx Volha Shmidt1, David Kaftan 1,2, Avigdor Scherz3 & Avihai Danon3 Targeting mutations to specifc genomic loci is invaluable for assessing in vivo the efect of these changes on the biological role of the gene in study. Here, we attempted to introduce a mutation that was previously implicated in an increased heat stability of the mesophilic cyanobacterium Synechocystis sp. PCC6803 via homologous recombination to the psbA gene of Chlamydomonas reinhardtii. For that, we established a strategy for targeted mutagenesis that was derived from the efcient genome- wide homologous-recombination-based methodology that was used to target individual genes of Saccharomyces cerevisiae. While the isolated mutants did not show any beneft under elevated temperature conditions, the new strategy proved to be efcient for C. reinhardtii even in the absence of direct positive selection. Te unicellular green alga Chlamydomonas reinhardtii has served as a primary platform for studies of photosyn- thesis in eukaryotes1–3, thus, making it a favorable target for studying the phenotypic consequences of the muta- tions in the D1 protein. D1 is encoded by the chloroplast psbA gene that has two identical copies in C. reinhardtii located in the inverted repeats4. Te C. reinhardtii psbA gene contains 4 introns that increase the size of the C. reinhardtii psbA gene up to roughly 7 kb4,5 and, in turn, complicate its genetic manipulation. Te modifcation of C. reinhardtii plastome is facilitated by an efcient homologous recombination6 that similarly to Saccharomyces cerevisiae7 and the moss Physcomitrella patens8 enables the targeting of exogenous homologous DNA to specifc sites in the chloroplast or nuclear genomes. -
Human Monocyte-To-Macrophage
Dekkers et al. Epigenetics & Chromatin (2019) 12:34 https://doi.org/10.1186/s13072-019-0279-4 Epigenetics & Chromatin RESEARCH Open Access Human monocyte-to-macrophage diferentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites Koen F. Dekkers1†, Annette E. Neele2†, J. Wouter Jukema3, Bastiaan T. Heijmans1*‡ and Menno P. J. de Winther2,4*‡ Abstract Background: Macrophages and their precursors monocytes play a key role in infammation and chronic infamma- tory disorders. Monocyte-to-macrophage diferentiation and activation programs are accompanied by signifcant epigenetic remodeling where DNA methylation associates with cell identity. Here we show that DNA methylation changes characteristic for monocyte-to-macrophage diferentiation occur at transcription factor binding sites, and, in contrast to what was previously described, are generally highly localized and encompass both losses and gains of DNA methylation. Results: We compared genome-wide DNA methylation across 440,292 CpG sites between human monocytes, naïve macrophages and macrophages further activated toward a pro-infammatory state (using LPS/IFNγ), an anti-infam- matory state (IL-4) or foam cells (oxLDL and acLDL). Moreover, we integrated these data with public whole-genome sequencing data on monocytes and macrophages to demarcate diferentially methylated regions. Our analysis showed that diferential DNA methylation was most pronounced during monocyte-to-macrophage diferentiation, was typically restricted to single CpGs or very short regions, and co-localized with lineage-specifc enhancers irrespec- tive of whether it concerns gain or loss of methylation. Furthermore, diferentially methylated CpGs were located at sites characterized by increased binding of transcription factors known to be involved in monocyte-to-macrophage diferentiation including C/EBP and ETS for gain and AP-1 for loss of methylation.